hsa_circ_0000285

ncRNA information

ncRNA name

hsa_circ_0000285

Specific or universal ncRNAs

Specific ncRNAs

Class

Circular RNA

Biomarker

Yes

Biomarker application

Prognosis

Upstream regulatory factors

Not available

Downstream target

Not available

Cancer information

Cancer name

Bladder Cancer

Cancer site

Bladder

Treatment information

Treatment type

Chemotherapy

Drug

Cisplatin

Impact of wild-type ncRNA on chemotherapy resistance

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Down

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Down

Number of patients

Not available

Male patients

Not available

Female patients

Not available

Age range and number

Not available

Research information

PMID

Description

Hsa_circ_0000285 expression was lower in cisplatin-resistant bladder cancer patients than in those who were cisplatin-sensitive.

Tissue resource

bladder cancer tissues and adjacent normal tissues

normal bladder epithelial cell lines CCC-HB-2

bladder cancer cell lines HTB-9

bladder cancer cell lines T24

bladder cancer cell lines J82

bladder cancer cell lines SW780

bladder cancer cell lines RT4

Experiment

qRT-PCR


Institute

the First Affiliated Hospital of Jiamusi University

the Chinese Academy of Sciences Cell Bank

Country

China

Continent

Asia